RecruitingNCT06927076
DMT and brain mechanisms linked to depression response
About this title
Read the official source — NCT06927076Medication studyAges 21+Switzerland
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 21 years. Other eligibility criteria apply.
- Listed locations
- BaselSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 5, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 112
- Sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Procedure
- Locations
- Switzerland
- Age range
- Over 21 Years
- Official registry ID
- NCT06927076
- Official title
Show the full official title
Investigating the Role of the Psychedelic Experience in the Antidepressant Response in Patients With Major Depression: a Placebo-controlled Factorial Trial With DMT Masked With Propofol (DMT4D-Study)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Basel
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Basel, Switzerland, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including N,N-Dimethyltryptamine and Placebo.
Who can participate?
This study is for people with depression. Listed age limits: from 21 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
